Li Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li Zhou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jinhui Tian
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China
2 shared publications - Tengfei Li
School of Nursing, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
2 shared publications - Bowa Zhang
School of Nursing, Gansu University of Chinese Medicine, Lanzhou, China
1 shared publication - Caihua Xu
Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University
1 shared publication - Mingyue Zhang
Evidence-Based Medicine Centre, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
1 shared publication - Qingyong Zheng
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China
1 shared publication
Latest Publications
- Open Access
- 18 October 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (48) , 5189
Subgroup effects of ticagrelor treatment strategies: credibility considerations in an individual patient data meta-analysis
This commentary refers to ‘Subgroup effects of ticagrelor monotherapy for acute coronary syndrome using individual patient data from the TICO and T-PASS trials’, by Y.J. Lee et al., https://doi.org/10.1093/eurheartj/ehae685, and the discussion piece ‘Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials’, by Y.J. Lee et al., https://doi.org/10.1093/eurheartj/ehae249.
- 18 October 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (48) , 5189
Open AccessSubgroup effects of ticagrelor treatment strategies: credibility considerations in an individual patient data meta-analysis
This commentary refers to ‘Subgroup effects of ticagrelor monotherapy for acute coronary syndrome using individual patient data from the TICO and T-PASS trials’, by Y.J. Lee et al., https://doi.org/10.1093/eurheartj/ehae685, and the discussion piece ‘Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials’, by Y.J. Lee et al., https://doi.org/10.1093/eurheartj/ehae249.
- 29 May 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (8) , 3543-3556
How consistent are the key recommendations, and what is the quality of guidelines and expert consensus regarding paediatric cow’s milk protein allergy?
The objective of this study was to assess the quality and consistency of recommendations in clinical practice guidelines (CPGs) and expert consensus on paediatric cow’s milk protein allergy (CMPA) to serve as a foundation for future revisions and enhancements of clinical guidelines and consensus documents. We conducted a comprehensive literature search across several databases, including the Chinese Biomedical Literature Database (CBM), PubMed, Embase, Web of Science, UpToDate, ClinicalKey, DynaMed Plus and BMJ Best Practice. We spanned the search period from the inception of each database through October 1, 2023. We integrated subject headings (MeSH/Emtree) and keywords into the search strategy, used the search methodologies of existing literature and developed it in collaboration with a librarian. Two trained researchers independently conducted the literature screening and data extraction. We evaluated methodological quality and recommendations by using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) and AGREE-Recommendations for Excellence (AGREE-REX) tools. Moreover, we compared and summarized key recommendations from high-quality CPGs. Our study included 27 CPGs and expert consensus documents on CMPA. Only four CPGs (14.8%) achieved a high-quality AGREE II rating. The four high-quality CPGs consistently provided recommendations for CMPA. The highest scoring domains for AGREE II were ‘scope and purpose’ (77 ± 12%) and ‘clarity of presentation’ (75 ± 22%). The lowest scoring domains were ‘stakeholder involvement’ (49 ± 21%), ‘rigor of development’ (34 ± 20%) and ‘applicability’ (12 ± 20%). Evaluation with AGREE-REX generally demonstrated low scores across its domains. Conclusion: Recommendations within high-quality CPGs for the paediatric CMPA showed fundamental consistency. Nevertheless, the methodology and recommendation content of CPGs and the expert consensus exhibited low quality, thus indicating a substantial scope for enhancement. Guideline developers should rigorously follow the AGREE II and AGREE-REX standards in creating CPGs or expert consensuses to guarantee their clinical efficacy in managing paediatric CMPA. What is Known: • The quality of clinical practice guidelines and expert consensus on paediatric cow's milk protein allergy (CMPA) remains uncertain. • There is a lack of clarity regarding the consistency of crucial recommendations for CMPA management. What is New: • Improving the methodological quality of guidelines and consensus on CMPA requires greater emphasis on stakeholder engagement, rigorous development processes, and practical applicability. • The recommendations from four high-quality guidelines align. However, addressing clinical applicability, integrating values and preferences, and ensuring actionable implementation are critical to improving the quality of all guidelines. Graphical Abstract
- 29 May 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (8) , 3543-3556
How consistent are the key recommendations, and what is the quality of guidelines and expert consensus regarding paediatric cow’s milk protein allergy?
The objective of this study was to assess the quality and consistency of recommendations in clinical practice guidelines (CPGs) and expert consensus on paediatric cow’s milk protein allergy (CMPA) to serve as a foundation for future revisions and enhancements of clinical guidelines and consensus documents. We conducted a comprehensive literature search across several databases, including the Chinese Biomedical Literature Database (CBM), PubMed, Embase, Web of Science, UpToDate, ClinicalKey, DynaMed Plus and BMJ Best Practice. We spanned the search period from the inception of each database through October 1, 2023. We integrated subject headings (MeSH/Emtree) and keywords into the search strategy, used the search methodologies of existing literature and developed it in collaboration with a librarian. Two trained researchers independently conducted the literature screening and data extraction. We evaluated methodological quality and recommendations by using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) and AGREE-Recommendations for Excellence (AGREE-REX) tools. Moreover, we compared and summarized key recommendations from high-quality CPGs. Our study included 27 CPGs and expert consensus documents on CMPA. Only four CPGs (14.8%) achieved a high-quality AGREE II rating. The four high-quality CPGs consistently provided recommendations for CMPA. The highest scoring domains for AGREE II were ‘scope and purpose’ (77 ± 12%) and ‘clarity of presentation’ (75 ± 22%). The lowest scoring domains were ‘stakeholder involvement’ (49 ± 21%), ‘rigor of development’ (34 ± 20%) and ‘applicability’ (12 ± 20%). Evaluation with AGREE-REX generally demonstrated low scores across its domains. Conclusion: Recommendations within high-quality CPGs for the paediatric CMPA showed fundamental consistency. Nevertheless, the methodology and recommendation content of CPGs and the expert consensus exhibited low quality, thus indicating a substantial scope for enhancement. Guideline developers should rigorously follow the AGREE II and AGREE-REX standards in creating CPGs or expert consensuses to guarantee their clinical efficacy in managing paediatric CMPA. What is Known: • The quality of clinical practice guidelines and expert consensus on paediatric cow's milk protein allergy (CMPA) remains uncertain. • There is a lack of clarity regarding the consistency of crucial recommendations for CMPA management. What is New: • Improving the methodological quality of guidelines and consensus on CMPA requires greater emphasis on stakeholder engagement, rigorous development processes, and practical applicability. • The recommendations from four high-quality guidelines align. However, addressing clinical applicability, integrating values and preferences, and ensuring actionable implementation are critical to improving the quality of all guidelines. Graphical Abstract